News - Vaccines, Financial


Current filters:


Popular Filters

Joint purchasing of vaccines and medicines becomes a reality in the EU

Joint purchasing of vaccines and medicines becomes a reality in the EU


The European Commission today approved a Joint Procurement Agreement, which will enable all European…

Antibiotics and Infectious diseasesEuropeFinancialMarkets & MarketingPharmaceuticalVaccines

Australia’s CSL posts solid half-year results

Australia’s CSL posts solid half-year results


Australian blood products and vaccine maker CSL reported a 3% rise in net profit to $646 million (all…

CSL LimitedFinancialHematologyPharmaceuticalVaccines

BNDES invests 804 million real in Novartis' new Brazil biotechnology unit

BNDES invests 804 million real in Novartis' new Brazil biotechnology unit


The Brazilian Development Bank will finance 804 million real ($342 million) for the construction of a…

BexseroBiotechnologyBrazilFinancialNovartisProductionSouth AmericaVaccines

New Zealand views addition of rotavirus, varicella vaccines to national immunization schedule


A vaccine for the gastric infection rotavirus and protection from varicella for the most vulnerable people…

FinancialHealthcareNew ZealandPfizerPharmaceuticalPrevenarVaccines

H1N1 virus market to be worth $273 million by 2018


The H1N1 vaccines market has been forecast to decline in value over the next five years, reaching a value…


Theravectys raises 14.7 million euros to help pursue vaccines development


French biotechnology company Theravectys has finalized a 14.7 million-euro ($19.9 million) financing…


HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst


While the risks involved in HIV vaccine development have turned Big Pharma away from pursuing a preventative…

Anti-viralsBiotechnologyFinancialHVTN 505PharmaceuticalResearchVaccines

Russian government to develop domestic production of vaccines


The Russian government is considering investing in the domestic production of vaccines, by building a…


BARDA continues Novavax' influenza vaccine programs following in-process review


USA-based clinical stage biopharmaceutical group Novavax (Nasdaq: NVAX) Novavax says that the US Department…

BiotechnologyFinancialNorth AmericaNovavaxResearchVaccines

Merck & Co to move HQ as part of cost-savings plan; enters deal with Vaxxas


US pharma giant Merck & Co (NYSE: MRK) is joining a string of drug majors in announcing cost-cutting…

FinancialLicensingMerck & CoPharmaceuticalVaccinesVaxxas

CSL Biotherapies gets US government contract for flu vaccines


CSL Biotherapies, a US subsidiary of Australia's CSL (ASX: CSL), one of the world's leading manufacturers…

CSL BiotherapiesCSL LimitedFinancialNorth AmericaPharmaceuticalProductionVaccines

Silencing investor concerns? Alnylam achieves RNAi milestone


US RNAi therapeutics specialties Alnylam Pharmaceuticals (Nasdaq: ALNY) has received a $3.2 million milestone…

Alnylam PharmaceuticalsAnti-viralsBiotechnologyFinancialGlaxoSmithKlineLicensingProductionVaccines

US government adds $32 million to Bavarian Nordic Imvamune contract


Denmark's Bavarian Nordic (Nasdaq OMX: BAVA) says that the US Department of Health and Human Services…

Bavarian NordicFinancialImvamuneNorth AmericaPharmaceuticalResearchVaccines

EU Commission clears 23 million-euro R&D aid to Novartis Italy for vaccines in developing countries


The European Commission has concluded that 23 million euros ($30.2 million) public funding, which Italy…


GlaxoSmithKline challenges Argentina court ruling


UK pharma giant GlaxoSmithKline (LSE: GSK) says it disagrees with the recent court ruling in favor of…

FinancialGlaxoSmithKlineLegalPharmaceuticalSouth AmericaSynflorixVaccines

RusNano to start production of vaccines and organogels


Russia’s RusNano (Russian Corporation of Nanotechnologies) has signed an agreement with Russian…

Anti-viralsBiotechnologyCardio-vascularEpidbiomedEuropeFinancialMarkets & MarketingMergers & AcquisitionsNanolekOncologyRusNanoVaccines

Stronger incentives for immunization of children in Australia


Australia’s childhood immunization arrangements are to be reformed with the aim of increasing the…


Russia’s RusNano invests in Selecta and BIND to develop and commercialize vaccines and cancer drugs


Two USA-based nano-medicines companies, BIND Biosciences and Selecta Biosciences, have entered into investment…

BIND BiosciencesBiotechnologyFinancialOncologyResearchRusNanoSelecta BiosciencesVaccines

Sanofi oral MS drug Aubagio shows strong efficacy in Ph III trial; plans massive Indian vaccine plant


French drug major Sanofi (Euronext: SAN) and its subsidiary Genzyme says that the results of a pivotal…


Emergent BioSolutions gets $1.25 billion BioThrax order for US government


Emergent BioSolutions (NYSE: EBS) revealed yesterday that it has received an award to supply the US government…

BioThraxEmergent BioSolutionsFinancialMarkets & MarketingNorth AmericaPharmaceuticalVaccines

Back to top